FDA Embassy Seminar: New Technology Challenges in Biologics

7/17/02


Click here to start


Table of Contents

FDA Embassy Seminar: New Technology Challenges in Biologics

PPT Slide

PPT Slide

PPT Slide

History of Biological Products Regulation

PPT Slide

PPT Slide

Forces Impacting the Regulation of Biological Products in the 21st Century

Regulation of Biological Products Based on Sound Science, Law and Public Health Impact

Human Genome

PPT Slide

New Discoveries:

New Discoveries: Technological advances

Analytical Challenges for Biologicals

Analytical Challenges for Biologicals

New Discoveries: Analytical approaches

Genomics

Proteomics

Bioinformatics

New Discoveries: Therapeutic products

Gene Therapy

Xenotransplantation

Impetus for Modern Xenotransplants

Public Health Dilemma

Regulatory Issues

“Xeno-tourism”

Societal Involvement

Stem Cells

Stem Cell Safety and Potency

Combination Products – “Tissue-engineered” products

Biological – Medical Device Combination Products

Tissue Engineering - Complexities

Examples of CBER regulated biologic-device combo products

Regulation of Tissue Engineered Products

PPT Slide

Author: Joan Blair

Home Page: http://www.fda.gov/oia/homepage.htm

Best experienced with
Microsoft Internet Explorer
Click here to start.